💨 Abstract
In the second quarter, Arcadia Biosciences (RKDA) reported a net loss of $4.5 million, or $3.26 per share. Adjusted earnings were 2 cents per share. The company's revenue for the period was $1.5 million.
Courtesy: WTOP Staff
Suggested
Heat and thirst drive families in Gaza to drink water that makes them sick -
In his push for fairness in college admissions, Trump has been silent on legacy preferences -
Music Review: Conan Gray’s ‘Wishbone’ further confirms his place as a tastemaker of Gen Z pop -
UnitedHealth Group shares climb as Buffett’s Berkshire Hathaway discloses stake in the insurer -
AC Milan signs Young Boys defender Athekame for 2nd major Swiss addition this month -
DC police say they’re focused on the community, but questions remain about who’s in charge -
Pope Leo XIV prays for peace as US-Russia summit over Ukraine war gets underway -
Rising heavyweight star Moses Itauma faces his toughest test in Dillian Whyte -
Australian and Philippine forces launch largest military exercises near disputed South China Sea -
Man United signs Rolfo after her 4-year stint at Barcelona -